Clinical Trial Update: Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440 [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating concomitant administration of the Japanese encephalitis vaccine IC51 with HARVIX 1440; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis

Drugs mentioned

• HARVIX 1440
• Japanese Encephalitis Vaccine IC51 (inactivated Japanese encephalitis vaccine IC51)

Snippet

Sponsor: Valneva Austria GmbH | Conditions: Japanese Encephalitis | Phase 3 | Status: COMPLETED | Results posted: 2014-05-13